Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer Stage IV

Explore clinical trials studying Non-small Cell Lung Cancer Stage IV. Study availability and eligibility vary by location and protocol.

17 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer Stage IV trial results

Completed

Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis

NCT03526900

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Hospital General Universitario de Elche Elche, Alicante, Spain
  • Hospital Universitari Germans Tries i Pujol Badalona, Barcelona, Spain
  • Hospital Universitari de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Complejo Hospitalario de la Coruña A Coruña, Coruña, Spain
View all 15 locations
View Trial Details
Completed

A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

NCT02450539

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Cancer Center of Kansas, P.A. Wichita, Kansas, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Montefiore Medical Center The Bronx, New York, United States
View all 51 locations
View Trial Details
Completed

Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC

NCT02047344

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • UCSF San Francisco, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • John Hopkins University Baltimore, Maryland, United States
View Trial Details
Completed

Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial

NCT02176369

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Ospedale di Gesù Fatebenefratelli Benevento, BN, Italy
  • ASL Brindisi - Stabilimento Ospedaliero Di Summa-Perrino Brindisi, BR, Italy
  • ASP di Bolzano - Comprensorio sanitario di Bolzano Bolzano, BZ, Italy
  • Ospedale Civile SS. Annunziata Chieti, CH, Italy
View all 20 locations
View Trial Details
Completed

SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

NCT01086254

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sanofi-Aventis Investigational Site Number 250002 Caen, France
  • Sanofi-Aventis Investigational Site Number 250003 Marseille, France
  • Sanofi-Aventis Investigational Site Number 250004 Toulouse, France
  • Sanofi-Aventis Investigational Site Number 250001 Villejuif, France
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

NCT06348199

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • SB Investigative Site Banja Luka, Bosnia and Herzegovina
  • SB Investigative Site Mostar, Bosnia and Herzegovina
  • SB Investigative Site Sarajevo, Bosnia and Herzegovina
  • SB Investigative Site Curitiba, Brazil
View all 93 locations
View Trial Details
Active, Not Recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details

Related conditions